MedTrace Logo

Vitamin D and Pregnancy Outcome in PCOS Patients

NCT04082650 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 876

Last updated 2025-01-29

No results posted yet for this study

Summary

This multicenter double-blinded placebo-controlled randomised trial aims to evaluate the effectiveness of vitamin D supplementation prior to IVF on the live birth rate in women with PCOS. Women with PCOS scheduled for IVF will be enrolled. Eligible participants will be randomised 1:1 to receive oral capsules of 4000IU vitamin D per day or placebo for around 12 weeks until the day of triggering.

Conditions

  • Polycystic Ovary Syndrome
  • in Vitro Fertilization

Interventions

DRUG

vitamin D

4000IU per day

OTHER

Placebo

The same doses with vitamin D

Sponsors & Collaborators

  • Women's Hospital School Of Medicine Zhejiang University

    lead OTHER

Principal Investigators

  • Dan Zhang, M.D. Ph.D. · Women's Hospital School Of Medicine Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2024-05-23
Completion
2025-01-27

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04082650 on ClinicalTrials.gov